- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunotherapies targeting stimulatory pathways and beyond ; volume:14 ; number:1 ; day:12 ; month:5 ; year:2021 ; pages:1-31 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (12.5.2021), 1-31, 12.2021
- Creator
-
Marin-Acevedo, Julian A.
Kimbrough, ErinMarie O.
Manochakian, Rami
Zhao, Yujie
Lou, Yanyan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01085-3
- URN
-
urn:nbn:de:101:1-2021091221463549409536
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marin-Acevedo, Julian A.
- Kimbrough, ErinMarie O.
- Manochakian, Rami
- Zhao, Yujie
- Lou, Yanyan
- SpringerLink (Online service)
Other Objects (12)
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies